Please use this identifier to cite or link to this item:
Human Genetic Intervention: How Far Should We Go?
|Title:||Human Genetic Intervention: How Far Should We Go?|
|Authors:||Nunes, Lance Gregory A.|
|Date Issued:||15 Nov 2018|
|Abstract:||Since the beginning of time, man has treated illness and disease with natural remedies. With the advancement in knowledge and technology, new kinds of treatments have entered the realm of medicine—namely genetic intervention. This paper aims to help determine where we should take our development of this technology. In each branch of genetic intervention—whether it be gene therapy, prevention, remediation, or enhancement—issues of ethics, socio-economics, and religion have casted a cloud over the technology, hindering its progression. In contrary, the power to improve the quality and save the lives of individuals affected by genetic diseases does not fail to fuel the fire behind advancement in research. From successful cases like Elisabeth Hartmann and Molly Nash’s to cases with undesirable outcomes like Jesse Gelsinger’s and the adenosine deaminase|
French gene therapy trials’, one thing stood out in the mix to help us determine
where we should draw the line that should not be crossed—intent. Three areas of genetic intervention seem to not cross that line: gene therapy, prevention, and remediation. However, based off intent, enhancement proves to be the most controversial branch of genetic intervention and gives insight as to where exactly that line should be drawn.
|Appears in Collections:||
Horizons, Volume 3|
Please email firstname.lastname@example.org if you need this content in ADA-compliant format.
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.